earnings
RN
NASDAQ · RNXT
RenovoRx, Inc.
Healthcare · Biotechnology
$1.39
Up+$0.00 (+0.00%)
Updated Oct 7, 2026, 7:15 PM
SID Score
5.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 36.39M
- P/E ratio
- -3.41
- Dividend yield
- 0.00%
- 52-week range
- $0.77 – $2.59
- Volume
- 621.68K
- Avg. volume
- 506.07K
Price performance · RNXT
RNXT price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 6, 2026
RNXT closed at $1.39 after 21 trading sessions, down 36.82% for the selected period.
- Last close
- $1.39
- Period change
- -36.82%
- Period low
- $1.39
- Period high
- $2.20
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 6, 2026 | $1.51 | $1.57 | $1.37 | $1.39 | 621.68K |
| Oct 5, 2026 | $1.58 | $1.61 | $1.43 | $1.47 | 618.03K |
| Oct 2, 2026 | $1.57 | $1.61 | $1.55 | $1.58 | 269.37K |
| Oct 1, 2026 | $1.57 | $1.59 | $1.5001 | $1.55 | 404.03K |
| Sep 30, 2026 | $1.57 | $1.64 | $1.54 | $1.56 | 397.96K |
| Sep 29, 2026 | $1.57 | $1.59 | $1.51 | $1.57 | 370.92K |
| Sep 28, 2026 | $1.65 | $1.65 | $1.50 | $1.55 | 877K |
| Sep 25, 2026 | $1.69 | $1.725 | $1.6454 | $1.66 | 490.85K |
| Sep 24, 2026 | $1.61 | $1.70 | $1.53 | $1.68 | 630.07K |
| Sep 23, 2026 | $1.70 | $1.7999 | $1.60 | $1.63 | 765.01K |
| Sep 22, 2026 | $1.70 | $1.73 | $1.67 | $1.70 | 383.95K |
| Sep 21, 2026 | $1.69 | $1.74 | $1.6301 | $1.67 | 482.55K |
| Sep 18, 2026 | $1.74 | $1.75 | $1.67 | $1.69 | 566.88K |
| Sep 17, 2026 | $1.60 | $1.77 | $1.58 | $1.73 | 636.08K |
| Sep 16, 2026 | $1.73 | $1.73 | $1.55 | $1.55 | 1.04M |
| Sep 15, 2026 | $1.692 | $1.73 | $1.60 | $1.72 | 1.03M |
| Sep 14, 2026 | $1.75 | $1.85 | $1.66 | $1.69 | 579.67K |
| Sep 11, 2026 | $1.77 | $1.8199 | $1.67 | $1.76 | 1.17M |
| Sep 10, 2026 | $1.97 | $1.99 | $1.71 | $1.77 | 1.64M |
| Sep 9, 2026 | $2.15 | $2.30 | $1.935 | $1.995 | 1.73M |
| Sep 8, 2026 | $2.31 | $2.345 | $2.1509 | $2.20 | 1.21M |
Latest RNXT news
The latest Smart Investors Daily articles mentioning RNXT.
Stock researchResearch & News · Competitors
Company
Market Activity
Research & News
Loading stock research…

